Fabrício Rodrigues Torres de Carvalho

Dr. Fabrício Rodrigues Torres de Carvalho

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2021 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
TCThiago Domingos Corrêa
Thiago Domingos Corrêa
TMThais Dias Midega
Thais Dias Midega
KTKarina Tavares Timenetsky
Karina Tavares Timenetsky
RCRicardo Luiz Cordioli
Ricardo Luiz Cordioli
CBCarmen Silvia Valente Barbas
Carmen Silvia Valente Barbas
LFLeonardo José Rolim Ferraz
Leonardo José Rolim Ferraz
Objective: To describe clinical characteristics, resource use, outcomes, and to identify predictors of in-hospital mortality of patients with COVID-19 admitted to the intensive care unit. Methods: Retrospective single-center cohort study conducted at a private hospital in São Paulo (SP), Brazil. All consecutive adult (≥18 years) patients admitted to the intensive care unit, between March 4, 2020 and February 28, 2021 were included in this study. Patients were categorized between survivors and non-survivors according to hospital discharge. Results: During the [...] ABSTRACT Objective: To describe clinical characteristics, resource use, outcomes, and to identify predictors of in-hospital mortality of patients with COVID-19 admitted to the intensive care unit. Methods: Retrospective single-center cohort study conducted at a private hospital in São Paulo (SP), Brazil. All consecutive adult (≥18 years) patients admitted to the intensive care unit, between March 4, 2020 and February 28, 2021 were included in this study. Patients were categorized between survivors and non-survivors according to hospital discharge. Results: During the

12 March 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
FCFabrício Rodrigues Torres de Carvalho
Fabrício Rodrigues Torres de Carvalho
JTJoao Paulo Telles
Joao Paulo Telles
FTFelipe Francisco Tuon
Felipe Francisco Tuon
RFRoberto Rabello Filho
Roberto Rabello Filho
PCPedro Caruso
Pedro Caruso
TCThiago Domingos Correa
Thiago Domingos Correa
Antibiotics misuse and overuse are concerning issues worldwide, especially in low middle-income countries. These practices contribute to the increasing rates of antimicrobial resistance. One efficient strategy to avoid them is antimicrobial stewardship programs. In this review, we focus on the possible approaches to spare the prescription of polymyxins and carbapenems for the treatment of Acinetobacter baumannii, carbapenem-resistant Enterobacterales, and Pseudomonas aeruginosas infections. Additionally, we highlight how to implement cumulative antibiograms and biomarkers to a sooner de-escalation of antibiotics.

29 May 2020 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
TCThiago Domingos Corrêa
Thiago Domingos Corrêa
GMGustavo Faissol Janot de Matos
Gustavo Faissol Janot de Matos
BBBruno de Arruda Bravim
Bruno de Arruda Bravim
RCRicardo Luiz Cordioli
Ricardo Luiz Cordioli
AGAlejandra del Pilar Gallardo Garrido
Alejandra del Pilar Gallardo Garrido
LFLeonardo José Rolim Ferraz
Leonardo José Rolim Ferraz
In December 2019, a series of patients with severe pneumonia were identified in Wuhan, Hubei province, China, who progressed to severe acute respiratory syndrome and acute respiratory distress syndrome. Subsequently, COVID-19 was attributed to a new betacoronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Approximately 20% of patients diagnosed as COVID-19 develop severe forms of the disease, including acute hypoxemic respiratory failure, severe acute respiratory syndrome, acute respiratory distress syndrome and acute renal failure and require intensive care. There is no randomized controlled clinical trial addressing potential therapies for patients with confirmed COVID-19 infection at the time of publishing these treatment recommendations. Therefore, these recommendations are based predominantly on the opinion of experts (level C of recommendation).

31 July 2020 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
TCThiago Domingos Corrêa
Thiago Domingos Corrêa
GMGustavo Faissol Janot de Matos
Gustavo Faissol Janot de Matos
BBBruno de Arruda Bravim
Bruno de Arruda Bravim
RCRicardo Luiz Cordioli
Ricardo Luiz Cordioli
AGAlejandra del Pilar Gallardo Garrido
Alejandra del Pilar Gallardo Garrido
LFLeonardo José Rolim Ferraz
Leonardo José Rolim Ferraz
Dear Editor, In this issue of einstein journal (São Paulo), Corrêa et al., reported intensive support recommendations for critically-ill patients with suspected or confirmed infection by the new coronavirus (COVID-19).() Based on preliminary demonstration of efficacy of chloroquine, the authors suggested the use of hydroxychloroquine in monotherapy or combined with a macrolide (azithromycin or clarithromycin), to treat severe patients with COVID-19, admitted to the intensive care unit (ICU), to inhibit in vitro replication of severe acute respiratory syndrome coronavirus 2 [...] Dear Editor, In this issue of einstein journal (São Paulo), Corrêa et al., reported intensive support recommendations for critically-ill patients with suspected or confirmed infection by the new coronavirus (COVID-19).() Based on preliminary demonstration of efficacy of chloroquine, the authors suggested the use of hydroxychloroquine in monotherapy or combined with a macrolide (azithromycin or clarithromycin), to treat severe patients with COVID-19, admitted to the intensive care unit (ICU), to inhibit in vitro replication of severe acute respiratory syndrome coronavirus 2

5 July 2023 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
TCThiago Domingos Corrêa
Thiago Domingos Corrêa
TMThais Dias Midega
Thais Dias Midega
RCRicardo Luiz Cordioli
Ricardo Luiz Cordioli
CBCarmen Silvia Valente Barbas
Carmen Silvia Valente Barbas
RFRoberto Rabello Filho
Roberto Rabello Filho
LFLeonardo José Rolim Ferraz
Leonardo José Rolim Ferraz
Highlights We compared characteristics between patients admitted during the first and second waves. There were 1,427 intensive care unit patients with COVID-19: 421 (first wave) and 1,006 (second wave). The patients in the second wave were younger and less severely ill at the time of intensive care unit admission. Patients exhibited similar mortality rates and need for invasive organ support. ABSTRACT Objective To describe and compare the clinical characteristics and outcomes of patients admitted to intensive care units during the

21 February 2019 in Current Treatment Options in Infectious Diseases
Verified
Journal Article
Closed access
PDF file
FCFabrício Rodrigues Torres de Carvalho
Fabrício Rodrigues Torres de Carvalho
RFRoberto Rabello Filho
Roberto Rabello Filho
LBLucas Bulgarelli
Lucas Bulgarelli
ANAry Serpa Neto
Ary Serpa Neto
RDRodrigo Octavio Deliberato
Rodrigo Octavio Deliberato